The Discounted Cash Flow (DCF) valuation of Intra-Cellular Therapies Inc (ITCI) is (2,208.54) USD. With the latest stock price at 80.39 USD, the upside of Intra-Cellular Therapies Inc based on DCF is -2847.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 9.0% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (12,718.31) - (1,211.79) | (2,208.54) |
| Upside | -15920.8% - -1607.4% | -2847.3% |